Blueshift Asset Management’s Health Catalyst HCAT Stock Holding History

Blueshift Asset Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,725	Closed	-$306K	–	959
2021 Q4	$306K	Buy	+7,725	New	+$352K	0.03%	619
2021 Q2	–	Sell	-7,224	Closed	-$338K	–	1014
2021 Q1	$338K	Buy	+7,224	New	+$350K	0.03%	601

Other funds holding HCAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Blueshift Asset Management's HCAT Position: Q1 2022 in Review

Blueshift Asset Management sold out of Health Catalyst (HCAT) in Q1 2022, closing a stake of 7,725 shares — an estimated $306K sold.

Blueshift Asset Management first reported a position in HCAT in Q1 2021 and held it in 2 quarters. The position peaked at $338K in Q1 2021. 185 funds tracked by Wall St. Rank hold HCAT as of Q1 2022.

Blueshift Asset Management reported no remaining Health Catalyst position as of Q1 2022 after selling out during the quarter.
Blueshift Asset Management sold 7,725 Health Catalyst shares in Q1 2022, an estimated $306K.
Blueshift Asset Management first reported a position in Health Catalyst in Q1 2021 and held it in 2 quarters.
Blueshift Asset Management's Health Catalyst position peaked at $338K in Q1 2021.
185 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2022.

Based on Blueshift Asset Management's 13F filing for Q1 2022, filed 12 May 2022.